CCN2 and metabolic dysfunction-associated steatotic liver disease: This suggests that the level of CTGF (either full-length or N-terminal fragment) was not correlated with the liver fibrosis stage in patients with NAFLD, even considering the baseline differences in the CTGF level between individual patients.